Japan Agency for Medical Research and Development

YOSHIOKA Kotaro, PhD, MD | Tokyo Medical and Dental University;
Competition Sponsor: Japan Agency for Medical Research and Development
Awardee Year: 2023 Nucleic acid therapeutics are rapidly advancing as a new class of molecular-targeting drugs following antibody therapies. However, two main challenges remain: inadequate drug delivery to target tissues and…

HATTORI Nobutaka, MD, PhD | Juntendo University School of Medicine; SAIKI Shinji, MD, PhD; SAKO Wataru, MD, PhD
Competition Sponsor: Japan Agency for Medical Research and Development
Awardee Year: 2023 With the aging of society, the number of patients with neurodegenerative diseases, especially Parkinson’s disease (PD), for which aging…